Spironolactone improves angiotensin-induced vascular changes and oxidative stress

被引:338
作者
Virdis, A [1 ]
Neves, MF [1 ]
Amiri, F [1 ]
Viel, E [1 ]
Touyz, RM [1 ]
Schiffrin, EL [1 ]
机构
[1] Univ Montreal, Multidisciplinary Res Grp Hypertens, Clin Res Inst Montreal, Montreal, PQ H2W 1R7, Canada
关键词
aldosterone; angiotensin II; endothelium; hypertension; arterial; oxidative stress; remodeling; rats;
D O I
10.1161/01.HYP.0000034738.79310.06
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Angiotensin II plays an important role in vascular remodeling. We investigated the role of aldosterone, which is stimulated by angiotensin II, as a mediator of angiotensin II-induced vascular structural and functional alterations. Sprague-Dawley rats (n=8 to 12/group) received angiotensin II (120 ng/kg per minute, subcutaneously) for 14 days spironolactone or hydralazine (25 mg/kg per day). An additional group received aldosterone (750 ng/h, subcutaneously) +/- spironolactone. Systolic blood pressure was increased by angiotensin II (P<0.001) and reduced by spironolactone and hydralazine (P<0.001). Aldosterone-induced increase of blood pressure was reduced by spironolactone (P<0.05). In mesenteric small arteries studied on a pressurized myograph, media/lumen ratio was increased (P<0.001) and acetylcholine-mediated relaxation was impaired in angiotensin II-infused rats (P<0.001); both were partially improved by spironolactone (P<0.05) but not by hydralazine. Aldosterone-induced increase of media/lumen ratio (P<0.001) and impaired response to acetylcholine (P<0.001) were normalized by spironolactone. Response to sodium nitroprusside was similar in all groups. Aortic NADPH oxidase activity was increased (P<0.01) by angiotensin II and reduced by spironolactone and hydralazine. Aldosterone also increased (P<0.05) activation of NADPH oxidase, an effect abolished by spironolactone. Plasma thiobarbituric acid-reactive substances (a marker of oxidative stress), higher in angiotensin II and aldosterone rats (P<0.001), were normalized by spironolactone. In conclusion, spironolactone, which inhibited aldosterone actions, partially corrected structural and functional angiotensin II-induced abnormalities. These effects were associated with reduced vascular NADPH oxidase activity and decreased plasma markers of oxidative stress. Our findings suggest that aldosterone may mediate some of angiotensin II-induced vascular effects in hypertension, in part via increased oxidative stress.
引用
收藏
页码:504 / 510
页数:7
相关论文
共 41 条
[1]   ETA receptor blockade prevents increased tissue endothelin-1, vascular hypertrophy, and endothelial dysfunction in salt-sensitive hypertension [J].
Barton, M ;
d'Uscio, LV ;
Shaw, S ;
Meyer, P ;
Moreau, P ;
Lüscher, TF .
HYPERTENSION, 1998, 31 (01) :499-504
[2]   Endothelial dysfunction in cardiovascular diseases - The role of oxidant stress [J].
Cai, H ;
Harrison, DG .
CIRCULATION RESEARCH, 2000, 87 (10) :840-844
[3]   Antioxidant effects of vitamins C and E are associated with altered activation of vascular NADPH oxidase and superoxide dismutase in stroke-prone SHR [J].
Chen, X ;
Touyz, RM ;
Park, JB ;
Schiffrin, EL .
HYPERTENSION, 2001, 38 (03) :606-611
[4]   In vivo study of AT1 and AT2 angiotensin receptors in apoptosis in rat blood vessels [J].
Diep, QN ;
Li, JS ;
Schiffrin, EL .
HYPERTENSION, 1999, 34 (04) :617-624
[5]   Tissue angiotensin and pathobiology of vascular disease - A unifying hypothesis [J].
Dzau, VJ .
HYPERTENSION, 2001, 37 (04) :1047-1052
[6]   Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failure [J].
Farquharson, CAJ ;
Struthers, AD .
CIRCULATION, 2000, 101 (06) :594-597
[7]   Mineralocorticoid receptor affects AP-1 and nuclear factor-κB activation in angiotensin II-Induced cardiac injury [J].
Fiebeler, A ;
Schmidt, F ;
Müller, DN ;
Park, JK ;
Dechend, R ;
Bieringer, M ;
Shagdarsuren, E ;
Breu, V ;
Haller, H ;
Luft, FC .
HYPERTENSION, 2001, 37 (02) :787-793
[8]   p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats [J].
Fukui, T ;
Ishizaka, N ;
Rajagopalan, S ;
Lauren, JB ;
Capers, Q ;
Taylor, WR ;
Harrison, DG ;
deLeon, H ;
Wilcox, JN ;
Griendling, KK .
CIRCULATION RESEARCH, 1997, 80 (01) :45-51
[9]   NAD(P)H oxidase - Role in cardiovascular biology and disease [J].
Griendling, KK ;
Sorescu, D ;
Ushio-Fukai, M .
CIRCULATION RESEARCH, 2000, 86 (05) :494-501
[10]   ANGIOTENSIN-II CAUSES VASCULAR HYPERTROPHY IN PART BY A NON-PRESSOR MECHANISM [J].
GRIFFIN, SA ;
BROWN, WCB ;
MACPHERSON, F ;
MCGRATH, JC ;
WILSON, VG ;
KORSGAARD, N ;
MULVANY, MJ ;
LEVER, AF .
HYPERTENSION, 1991, 17 (05) :626-635